Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
The new drug, Kisunla, has the potential to be a blockbuster for the company and generate billions in revenue. But despite ...
Fox 42d
New Alzheimer's infusion hits market, SWFL woman one of first to get it
The US Food and Drug Administration approved Donanemab, also called Kisunla. Tuesday's decision put the monoclonal antibody ...
Why new treatments for Alzheimer's cost tens of thousands of dollars a year
The Food and Drug Administration approved a new Eli Lilly drug this month that treats Alzheimer's disease. Kisunla is an IV ...
WLRN1d
New drug gives hope to South Floridians affected by Alzheimer’s
Called Donanemab, this treatment from Eli Lilly will be sold under its brand name, Kisunla, and works as an intravenous ...
Is Eli Lilly Stock a No-Brainer Buy After Its FDA Alzheimer's Disease Drug Win?
Lilly argues that Kisunla could be less costly to payers than rivals. It's the only FDA-approved Alzheimer's disease drug ...
Knowridge4d
Why new Alzheimer’s drug is so expensive
The Food and Drug Administration (FDA) recently approved a new drug from Eli Lilly to treat Alzheimer’s disease. Called ...
Eli Lilly's Donanemab Approval Heats Up Alzheimer's Disease Treatment Market | DelveInsight
Alzheimer's disease, the most common type of dementia, is a progressive neurodegenerative disorder with a multifactorial ...
KSL11d
New Alzheimer's drug wins approval after FDA delay
The U.S. Food and Drug Administration on Tuesday approved another drug that slows cognitive and functional decline in people ...
Bill McEwen9d
FDA Approves Second Drug to Modestly Slow Alzheimer's Disease
Learn about the benefits of Kisunla, the newly approved Alzheimer's drug that can modestly slow disease progression in the ...
BioSpace3d
Novo Holdings Leads $100M Raise for Asceneuron’s Alzheimer’s Push
Asceneuron, which develops small molecules targeting tau protein aggregation, plans to use the funds to advance its Alzheimer ...
Yahoo Finance6d
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
Eli Lilly (NYSE: LLY) received some great news from regulators last week: Its Alzheimer's treatment obtained the green light from the Food and Drug Administration (FDA). The new drug, Kisunla ...
health.wusf.usf.edu1d
New drug gives hope to Floridians affected by Alzheimer’s disease
The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.